Calpeptin-DataSheet-生命科学试剂-MedChemExpress

Hotline:400-820-3792Inhibitors•Agonists•ScreeningLibrarieswww.MedChemECalpeptinCat.No.:HY-100223CASNo.:117591-20-5分⼦式:C₂₀H₃₀N₂O₄分⼦量:362.46作⽤靶点:Cathepsin;Proteasome;Apoptosis作⽤通路:MetabolicEnzyme/Protease;Apoptosis储存⽅式:Powder-20°C3years4°C2yearsInsolvent-80°C6months-20°C1month溶解性数据体外实验DMSO:100mg/mL(275.89mM;Needultrasonic)扫描⼆维码，H2O:<0.1mg/mL(insoluble)运⽤溶解⽅案计算器获得适合您实验体系的溶解⽅案MassSolvent1mg5mg10mgConcentration制备储备液1mM2.7589mL13.7946mL27.5893mL5mM0.5518mL2.7589mL5.5179mL10mM0.2759mL1.3795mL2.7589mL请根据产品在不同溶剂中的溶解度，选择合适的溶剂配制储备液，并请注意储备液的保存⽅式和期限。体内实验请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照InVitro⽅式配制澄的储备液，再依次添加助溶剂：为保证实验结果的可靠性，澄的储备液可以根据储存条件，适当保存；体内实验的⼯作液，建议您现⽤现配，当天使⽤；以下溶剂前显⽰的百分⽐指该溶剂在您配制终溶液中的体积占⽐；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的⽅式助溶1.请依序添加每种溶剂：10%DMSO40%PEG3005%Tween-8045%salineSolubility:≥2.5mg/mL(6.90mM);Clearsolution此⽅案可获得≥2.5mg/mL(6.90mM，饱和度未知)的澄溶液。以1mL⼯作液为例，取100μL25.0mg/mL的澄DMSO储备液加到400μLPEG300中，混合均匀；向上述体系中加⼊50μLTween-80，混合均匀；然后继续加⼊450μL⽣理盐⽔定容⾄1mL。1/3www.MedChemEwww.MedChemE2.请依序添加每种溶剂：10%DMSO90%cornoilSolubility:≥2.5mg/mL(6.90mM);Clearsolution此⽅案可获得≥2.5mg/mL(6.90mM，饱和度未知)的澄溶液，此⽅案不适⽤于实验周期在半个⽉以上的实验。以1mL⼯作液为例，取100μL25.0mg/mL的澄DMSO储备液加到900μL⽟⽶油中，混合均匀。BIOLOGICALACTIVITY⽣物活性Calpeptin⼀种有效的、具有细胞穿透性的calpain抑制剂，其对⼈⾎⼩板CalpainI的ID50值为40nM[1]。Calpeptin也cathepsinK的抑制剂[2]。IC50&TargetID50:40nM(CalpainIinhumanplatelets)[1].CthepsinK[2]体外研究Calpeptin(0-100nM,24hours)treatmentsuppressestheproliferationofbothWI38VA13andIMR90cellsinadose-dependentmanner.Calpeptin(1000pg/ml,24hours)inhibitsIL-6-inducedcellproliferationoflungfibroblasts[3].CellProliferationAssay[3]CellLine:WI38VA13andIMR90cellsConcentration:0-100nMIncubationTime:24hoursResult:Suppressedtheproliferationinadose-dependentmanner.体内研究CalpeptinwithBleo(0.04mg/mouse,i.p.,3timesweekly,28days)administrationsignificantlyinhibitsthecollagendepositionandincreasesofcalpainactivityintheNSC-125066treatedmouselungtissues[3].AnimalModel:C57BL/6femalemice(Eight-week-old)[3].Dosage:0.04mg/mouse.Administration:Intraperitoneallythreetimesweeklyfor28days(togetherwithBleo).Result:InhibitedthecollagendepositionandincreaseofcalpainactivityintheNSC-125066treatedmouselungtissues.户使⽤本产品发表的科研⽂献•JCellMolMed.2020Aug;24(16):9287-9299.•RSCAdv.2019,2019,9,25107-25118.•IntJMedSci.2021;18(8):1746-1752.2/3www.MedChemEwww.MedChemESeemorecustomervalidationsonwww.MedChemEREFERENCES[1].TsujinakaT,etal.Synthesisofanewcellpenetratingcalpaininhibitor(calpeptin).BiochemBiophysResCommun.1988Jun30;153(3):1201-8.[2].CatalanoJG,etal.Designofsmallmoleculeketoamide-basedinhibitorsofcathepsinK.BioorgMedChemLett.2004Feb9;14(3):719-22.[3].TabataC,etal.Thecalpaininhibitorcalpeptinpreventspulmonaryfibrosisinmice.ClinExpImmunol.2010Dec;162(3):560-7.McePdfHeight关注MCE中国公众号，

获取前沿资讯、最新活动和

实⽤科研⼯具MedChemExpress(MCE)只为有资质的科研机构、医药企业基于科学研究或药证申报的⽤途提供医药研发服务，不为任何个⼈或者⾮科研性质的